Helokinestatin: A new bradykinin B2 receptor antagonist decapeptide from lizard venom

Peptides

Volumn 29, Issue 1, 2008, Pages 65-72

  Kwok, Hang Fai ^a   Chen, Tianbao ^a   O'Rourke, Martin ^a   Ivanyi, Craig ^b   Hirst, David ^a   Shaw, Chris ^a  

^a UNIVERSITY OF ULSTER   (United Kingdom)

^b ARIZONA SONORA DESERT MUSEUM   (United States)

Author keywords

Bradykinin; Helokinestatin; Lizard; Mass spectroscopy; Venom peptides

Indexed keywords

AMINO ACID; BETA 2 ADRENERGIC RECEPTOR; BRADYKININ; BRADYKININ B2 RECEPTOR ANTAGONIST; GLYCYLPROLYLPROLYLTYROSYLGLUTAMINYLPROLYLLEUCYLVALYLPROLYLARGININE; HELOKINESTATIN; PEPTIDE DERIVATIVE; PHENYLEPHRINE; UNCLASSIFIED DRUG; VENOM;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTERY MUSCLE; ARTICLE; DOSE RESPONSE; LIZARD; MALE; MASS SPECTROMETRY; NONHUMAN; PRIORITY JOURNAL; PROTEIN ISOLATION; PROTEIN STRUCTURE; RAT; TAIL ARTERY; VASODILATATION;

ANIMALS; ARTERIES; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; LIZARDS; MALE; MUSCLE, SMOOTH, VASCULAR; OLIGOPEPTIDES; RATS; RATS, WISTAR; RECEPTOR, BRADYKININ B2; SPECIES SPECIFICITY; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION; TIME FACTORS; VENOMS;

HELODERMA HORRIDUM; HELODERMA SUSPECTUM; HELODERMATIDAE; RATTUS; REPTILIA; SQUAMATA;

EID: 37449020312     PISSN: 01969781     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.peptides.2007.10.025     Document Type: Article

References (28)

1. Alagon A.C., Maldonado M.E., Julia J.Z., Sanchez C.R., and Possani L.D. Venom from two sub-species of Heloderma horridum (Mexican beaded lizard): general characterisation and purification of N-benzoyl-l-arginine ethyl ester hydrolase. Toxicon 20 (1982) 463-475
2. Bertaccini G. Active polypeptides of nonmammlian origin. Pharm Rev 28 (1976) 127-177
3. Conlon J.M. Bradykinin and its receptors in non-mammalian vertebrates. Regul Pept 79 (1999) 71-81
4. Eng J., Kleinman W.A., Singh L., Singh G., and Raufman J.P. Isolation and characterisation of exendin-4, an exendin-3 analogue, from Heloderma suspectum venom. Further evidence for an exendin receptor on dispersed acini from guinea pig pancreas. J Biol Chem 267 (1992) 7402-7405
5. Erspamer V. Bioactive secretions of the integument. Amphibian Biology vol. 1 (1994), Surrey Beatty and Sons, Chipping Norton
6. Ferreira S.H., Bartelt D.C., and Greene L.J. Isolation of bradykinin-potentiating peptides from Bothrops jararaca venom. Biochemistry 9 (1970) 2586-2593
7. Ferreira L.A.F., Raida A.G.M., Schrader M., Lebrun I., and Habermehl G. Isolation: analysis and properties of three bradykinin-potentiating peptides (BPP-II, BPP-III, and BPP-V) from Bothrops neuwiedi venom. J Protein Chem 17 (1998) 285-289
8. Fry B.G., Vidal N., Norman J.A., Vonk F.J., Scheib H., Ramjan S.F., et al. Early evolution of the venom system in lizards and snakes. Nature 439 (2006) 584-588
9. Graham R.L.J., Graham C., McClean S., Chen T., O'Rourke M., Hirst D., et al. Identification and functional analysis of a novel bradykinin inhibitory peptide in the venoms of New World Crotalinae pit vipers. Biochem Biophys Res Commun 338 (2005) 1587-1592
10. Hall J.M. Bradykinin receptors. Gen Pharmacol 28 (1997) 1-6
11. Hung T.F., and Chiang H.S. Effect on human platelet aggregation of phospholipase A2 purified from Heloderma horridum (beaded lizard) venom. Biochem Biophys Acta 1211 (1994) 61-68
12. Levell J. A Field Guide to Reptiles and the Law (1997), Sang Froid Press, Inc., Canada
13. Meki A.R.M.A., Nassar A.Y., and Rochat H. A bradykinin-potentiating peptide (peptide K12) isolated from the venom of Egyptian scorpion, Buthus occitanus. Peptides 16 (1995) 1359-1365
14. Moro O., and Lerner E.A. Maxadilan, the vasodilator from sand flies, is a specific pituitary adenylate cyclase activating peptide type I receptor agonist. J Biol Chem 272 (1997) 966-970
15. Moser M. Current recommendations for the treatment of hypertension: Are they still valid?. J Hypertens 20 (2002) 3-10
16. Nikai T., Imai K., Sugihara H., and Tu A.T. Isolation and characterisation of horridum toxin with arginine ester hydrolase activity from Heloderma horridum (beaded lizard) venom. Arch Biochem Biophys 264 (1988) 270-280
17. Patterson R.A. Some physiological effects caused by venom from the Gila monster, Heloderma suspectum. Toxicon 5 (1967) 5-10
18. Patterson R.A. Smooth muscle stimulating action of venom from the Gila monster, Heloderma suspectum. Toxicon 5 (1967) 11-15
19. Raufman J.P. Bioactive peptides from lizard venoms. Regul Pept 61 (1996) 1-18
20. Regoli D., and Barabe J. Pharmacology of bradykinin and related kinins. Pharmacol Rev 32 (1980) 1-46
21. Regoli D., Rizzi A., and Cab G. Pharmacology of the kallikrein-kinin system. Pharmacol Res 35 (1997) 513-515
22. Regoli D., Nsa Allogho S., Rizzi A., and Gobeil F.J. Bradykinin receptors and their antagonists. Eur J Pharmacol 348 (1998) 1-10
23. Russell F.E., and Bogert C.M. Gila monster: its biology, venom, and bite-a review. Toxicon 19 (1981) 341-359
24. Russell F.E. Snake Venom Poisoning, Chapter 9: Gila monster (Heloderma suspectum) (1983), Scholium Int, Great Neck, New York
25. Sosa B.P., Alagon A.C., Martin M.B., and Possani L.D. Biochemical characterisation of the phospholipase A2 purified from the venom of the Mexican beaded lizard (Heloderma horridum horridum). Biochemistry 25 (1986) 2927-2933
26. Stewart J.M., Gera L., York E.J., Chan D.C., and Bunn P. Bradykinin antagonists: present progress and future prospects. Immunopharmacology 43 (1999) 155-161
27. Tu A.T., and Murdock S. Protein nature and some enzymatic properties of the lizard Heloderma suspectum suspectum (Gila monster) venom. Comp Biochem Physiol 22 (1967) 389-396
28. Tu A.T., and Hendon R.R. Characterisation of lizard venom hyaluronidase and evidence for its action as a spreading factor. Comp Biochem Physiol 76 (1983) 377-383